Abstract:Background: Previous large-scale studies of de novo variants identified a number of genes associated with neurodevelopmental disorders (NDDs); however, it was also predicted that many NDD-associated genes await discovery. Such genes can be discovered by integrating copy number variants (CNVs), which have not been fully considered in previous studies, and increasing the sample size. Methods: We first constructed a model estimating the rates of de novo CNVs per gene from several factors such as gene length and number of exons. Second, we compiled a comprehensive list of de novo single-nucleotide variants (SNVs) in 41,165 individuals and de novo CNVs in 3675 individuals with NDDs by aggregating our own and publicly available datasets, including denovo-db and the Deciphering Developmental Disorders study data. Third, summing up the de novo CNV rates that we estimated and SNV rates previously established, gene-based enrichment of de novo deleterious SNVs and CNVs were assessed in the 41,165 cases. Significantly enriched genes were further prioritized according to their similarity to known NDD genes using a deep learning model that considers functional characteristics (e.g., gene ontology and expression patterns). Results: We identified a total of 380 genes achieving statistical significance (5% false discovery rate), including 31 genes affected by de novo CNVs. Of the 380 genes, 52 have not previously been reported as NDD genes, and the data of de novo CNVs contributed to the significance of three genes (GLTSCR1, MARK2, and UBR3). Among the 52 genes, we reasonably excluded 18 genes [a number almost identical to the theoretically expected false positives (i.e., 380 × 0.05 = 19)] given their constraints against deleterious variants and extracted 34 "plausible" candidate genes. Their validity as NDD genes was consistently supported by their similarity in function and gene expression patterns to known NDD genes. Quantifying the overall similarity using deep learning, we identified 11 high-confidence (> 90% true-positive probabilities) candidate genes: HDAC2, SUPT16H, HECTD4, CHD5, XPO1, GSK3B, NLGN2, ADGRB1, CTR9, BRD3, and MARK2. Conclusions: We identified dozens of new candidates for NDD genes. Both the methods and the resources developed here will contribute to the further identification of novel NDD-associated genes.

Targeted sequencing and integrative analysis of 3,195 Chinese patients with neurodevelopmental disorders prioritized 26 novel candidate genes

Targeted sequencing and integrative analysis to prioritize candidate genes in neurodevelopmental disorders

Targeted Sequencing Identifies Risk Variants in 202 Candidate Genes for Neurodevelopmental Disorders

Targeted sequencing and functional analysis reveal brain-size-related genes and their networks in autism spectrum disorders

Targeted Resequencing of 358 Candidate Genes for Autism Spectrum Disorder in a Chinese Cohort Reveals Diagnostic Potential and Genotype-Phenotype Correlations

Identification of De Novo Mutations in the Chinese Autism Spectrum Disorder Cohort Via Whole-Exome Sequencing Unveils Brain Regions Implicated in Autism

Discovery and validation of novel genes in a large Chinese ASD cohort

Discovery and Validation of Novel Genes in a Large Chinese Autism Spectrum Disorder Cohort.

Whole-genome sequencing identifies novel genes for autism in Chinese trios

Targeted next generation sequencing in 112 Chinese patients with intellectual disability/developmental delay: novel mutations and candidate gene

Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing

Targeted Sequencing Identifies 91 Neurodevelopmental Disorder Risk Genes with Autism and Developmental Disability Biases

De Novo Mutation of Cancer-Related Genes Associates with Particular Neurodevelopmental Disorders

Cross-Disorder Analysis of De Novo Mutations in Neuropsychiatric Disorders

Genome-wide copy number variation analysis in a Chinese autism spectrum disorder cohort

Association Between De Novo Variants of Nuclear-Encoded Mitochondrial-Related Genes and Undiagnosed Developmental Disorder and Autism.

Nexus between genome-wide copy number variations and autism spectrum disorder in Northeast Han Chinese population

Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model

Molecular characterization for neurodevelopmental disorders by chromosomal microarray analysis

Large-scale discovery of novel neurodevelopmental disorder-related genes through a unified analysis of single-nucleotide and copy number variants

De Novo Variants in Chinese ASD Trios Reveal Distinct Genetic Basis Underlying Autism with and Without Developmental Delay